¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® : ¿¬·É´ëº°, ÃÖÁ¾»ç¿ëÀÚº°, À¯Çüº°, Áö¿ªº° Àü¸Á ¹× ¿¹Ãø(2024-2031³â)
Global Enteral Syringe Market Size, Share & Trends Analysis Report By Age Group (Adults and Pediatrics), By End User (Hospitals, Ambulatory Surgical Centers, and Homecare), By Type (Disposable and Reusable), By Regional Outlook and Forecast, 2024 - 2031
»óǰÄÚµå : 1534575
¸®¼­Ä¡»ç : KBV Research
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 226 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,600 £Ü 5,059,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,320 £Ü 6,071,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,048 £Ü 8,500,000
PDF (Corporate User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è °æÀå¿ë ½Ã¸°Áö ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ µ¿¾È 5.1%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2031³â±îÁö 5¾ï 5,690¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, ³ëÀεéÀº Á¾Á¾ Àü¹®ÀûÀÎ ¿µ¾ç º¸ÃæÀÌ ÇÊ¿äÇÑ °Ç°­ »óŸ¦ °¡Áö°í ÀÖ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¿µ¾ç½ÇÁ¶, ¿¬ÇÏÀå¾Ö(»ïŰ±â ¾î·Á¿ò), ¸¸¼ºÁúȯ°ú °°Àº Áõ»óÀº Á¾Á¾ °æÀ念¾ç ¼Ö·ç¼ÇÀ» ÇÊ¿ä·Î ÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¶ÇÇÑ ´ç´¢º´, ½ÉÀ庴, ¾Ï°ú °°Àº ¸¸¼º ÁúȯÀº ³ëÀÎÃþ¿¡¼­ ¸¹ÀÌ ¹ß»ýÇÕ´Ï´Ù. µû¶ó¼­ °í·ÉÈ­ Àα¸ÀÇ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

±×·¯³ª ÀÇ·á ½Ã¼³, ƯÈ÷ ¿¹»ê Á¦¾àÀÌ ½ÉÇÑ ÀÇ·á ½Ã¼³Àº °í±Þ ÁÖ»ç±â¿¡ ´ëÇÑ ÁöÃâÀ» Á¤´çÈ­Çϱâ À§ÇØ °í±ººÐÅõÇÒ ¼ö ÀÖ½À´Ï´Ù. ȯÀÚ, ƯÈ÷ Àú¼ÒµæÃþ ¹× ÀÇ·á ÀÚ±ÝÀÌ Á¦ÇÑµÈ Áö¿ªÀÇ È¯ÀÚ´Â °í±Þ ÁÖ»ç±âÀÇ ³ôÀº ºñ¿ëÀ¸·Î ÀÎÇØ °í±Þ ÁÖ»ç±â¿¡ ´ëÇÑ Á¢±ÙÀÌ Á¦ÇÑ µÉ ¼ö ÀÖ½À´Ï´Ù. °á·ÐÀûÀ¸·Î °í±Þ ÁÖ»ç±âÀÇ ³ôÀº ºñ¿ëÀÌ ½ÃÀå ¼ºÀåÀ» ¹æÇØÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ÆÒµ¥¹Í ±â°£ µ¿¾È ¼±ÅÃÀû ÀÇ·á ÀýÂ÷ ¹× Ä¡·áÀÇ ¿¬±â·Î ÀÎÇØ ƯÁ¤ ÀÇ·á ÇöÀå¿¡¼­´Â ÀÌ·¯ÇÑ ÁÖ»ç±âÀÇ Çʿ伺ÀÌ °¨¼ÒÇßÀ¸¸ç, COVID-19 À§±â·Î ÀÎÇÑ ÀÇ·á ½Ã¼³¿¡ ´ëÇÑ ¾ÐµµÀûÀÎ ¾Ð·ÂÀ¸·Î ÀÎÇØ Àå³» ¿µ¾ç °ø±ÞÀÌ ÇÊ¿äÇÑ È¯ÀÚÀÇ ÀÏ»óÀûÀÎ Ä¡·á ¹× °ü¸®°¡ ÁߴܵǾú½À´Ï´Ù. ÁÖ¿ä »ê¾÷ Çà»ç, ¹Ú¶÷ȸ ¹× ÄÁÆÛ·±½º°¡ Ãë¼ÒµÇ°Å³ª °¡»óÀ¸·Î °³ÃÖµÇ¾î ³×Æ®¿öÅ· ¹× ½ÃÀå ¼ºÀå ±âȸ°¡ Á¦ÇѵǾú½À´Ï´Ù. ÀÌó·³ COVID-19´Â ½ÃÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù.

¿¬·É´ë Àü¸Á

¿¬·É´ëº°·Î ½ÃÀåÀº ¼ºÀΰú ¼Ò¾Æ·Î ³ª´µ¸ç, 2023³â¿¡´Â ¼Ò¾Æ ºÎ¹®ÀÌ ½ÃÀå ¸ÅÃâ Á¡À¯À²ÀÇ 23%¸¦ Â÷ÁöÇß½À´Ï´Ù. ÀÇÇÐÀÇ ¹ßÀüÀ¸·Î Á¶»ê¾Æ ¹× ½É°¢ÇÑ °Ç°­ »óŸ¦ °¡Áø ¾î¸°ÀÌÀÇ »ýÁ¸À²ÀÌ Å©°Ô Çâ»óµÇ¾úÀ¸¸ç, À̵é Áß »ó´ç¼ö´Â °æÀ念¾çÀÌ ÇÊ¿äÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀå ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦2Àå ½ÃÀå ¿ä¶÷

Á¦3Àå ½ÃÀå °³¿ä

Á¦4Àå ¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå : ¿¬·ÉÃþº°

Á¦5Àå ¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦6Àå ¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå : À¯Çüº°

Á¦7Àå ¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå : Áö¿ªº°

Á¦8Àå ±â¾÷ °³¿ä

Á¦9Àå °æÀå¿ë ½Ã¸°Áö ½ÃÀåÀÇ ¼º°ø Çʼö Á¶°Ç

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Enteral Syringe Market size is expected to reach $556.9 million by 2031, rising at a market growth of 5.1% CAGR during the forecast period.

The prevalence of chronic diseases, such as cancer and cardiovascular conditions, is on the rise in the Asia-Pacific region. These conditions often require enteral feeding, increasing the demand for these syringes. Patients with chronic illnesses may need long-term nutritional support, which can be effectively managed using these syringes. Consequently, the Asia Pacific region would acquire nearly 30% of the total market share by 2031.

Adopting nutritional support therapy emphasizes personalized care tailored to individual patient needs. In addition, updated clinical guidelines and protocols now commonly include recommendations for nutritional support therapy as a standard practice for managing patients with specific health conditions. Hence, the increasing adoption of nutritional support therapy is driving the market's growth.

Additionally, Older adults frequently experience health conditions that necessitate specialized nutritional support. Conditions such as malnutrition, dysphagia (difficulty swallowing), and chronic illnesses often require enteral feeding solutions. Additionally, chronic diseases like diabetes, heart disease, and cancer are more common among the elderly population. Thus, the growing aging population is propelling the growth of the market.

However, Healthcare facilities, particularly those operating under tight budget constraints, may struggle to justify the expenditure on advanced syringes. Patients, especially those in lower-income brackets or regions with limited healthcare funding, may have restricted access to advanced syringes due to their high cost. In conclusion, the high cost of advanced syringes hampers the market's growth.

Moreover, the postponement of elective medical procedures and treatments during the pandemic decreased the need for these syringes in certain healthcare settings. The overwhelming pressure on healthcare facilities due to the COVID-19 crisis disrupted routine care and management of patients requiring enteral feeding. Major industry events, trade shows, and conferences were cancelled or held virtually, limiting networking and market growth opportunities. Thus, the COVID-19 had a negative impact on the market.

Age Group Outlook

On the basis of age group, the market is segmented into adults and paediatrics. In 2023, the paediatrics segment attained 23% revenue share in the market. Advances in medical care have significantly improved the survival rates of preterm infants and children with severe health conditions, many of whom require enteral feeding.

End User Outlook

By end user, the market is divided into hospitals, ambulatory surgical centres, and homecare. The homecare segment procured a 13% revenue share in the market in 2023. As the global population ages, more elderly individuals require long-term care, including enteral feeding, which can be effectively managed at home using these syringes.

Type Outlook

Based on type, the market is divided into reusable and disposable. The reusable segment procured 37% revenue share in the market in 2023. Although reusable syringes require an initial investment, they can be more cost-effective over time than disposable syringes. For healthcare facilities with high usage rates, the cumulative cost of disposables can be significantly higher.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed a 35% revenue share in the market in 2022. North America boasts a sophisticated healthcare system with numerous hospitals, clinics, and long-term care facilities equipped with advanced medical technologies, including these syringes.

List of Key Companies Profiled

Global Enteral Syringe Market Report Segmentation

By Age Group

By End User

By Type

By Geography

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Global Enteral Syringe Market by Age Group

Chapter 5. Global Enteral Syringe Market by End User

Chapter 6. Global Enteral Syringe Market by Type

Chapter 7. Global Enteral Syringe Market by Region

Chapter 8. Company Profiles

Chapter 9. Winning Imperatives for Enteral Syringe Market

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â